Health Catalyst(HCAT)

Search documents
Health Catalyst(HCAT) - 2022 Q2 - Earnings Call Transcript
2022-08-07 04:41
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Adam Brown – Senior Vice President-Finance and Investor Relations Dan Burton – Chief Executive Officer Bryan Hunt – Chief Financial Officer Conference Call Participants Anne Samuel – J.P. Morgan Jared Haase – William Blair Elizabeth Anderson – Evercore Stephanie Davis – SVB Securities John Ransom – Raymond James Jessica Tassan – Piper Sandler Richard Close – Canaccord Genuity Daniel Grosslight ...
Health Catalyst(HCAT) - 2022 Q2 - Quarterly Report
2022-08-04 23:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ...
Health Catalyst(HCAT) - 2022 Q1 - Earnings Call Transcript
2022-05-11 19:51
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sachs Elizabeth Anderson - Evercore Stephanie Davis - SVB Securities Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi David Larsen - BTIG Dev Weerasuriya - Berenberg Operator Go ...
Health Catalyst(HCAT) - 2022 Q1 - Quarterly Report
2022-05-10 20:34
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter ...
Health Catalyst(HCAT) - 2021 Q4 - Earnings Call Transcript
2022-03-02 07:30
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2021 Earnings Conference Call March 1, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sachs Elizabeth Anderson - Evercore ISI Stephanie Davis - SVB Leerink Richard Close - Canaccord Genuity John Ransom - Raymond James David Grossman - Stifel Glen Santangelo - Jefferies Operator Good day and thank you for standing by. Welc ...
Health Catalyst(HCAT) - 2021 Q4 - Annual Report
2022-03-01 21:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ Form 10-K _______________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in ...
Health Catalyst(HCAT) - 2021 Q3 - Earnings Call Transcript
2021-11-10 03:52
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2021 Earnings Conference Call November 9, 2021 5:00 PM ET Company Participants Adam Brown - Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Stephanie Davis - SVB Leerink David Grossman - Stifel Daniel Grosslight - Citi Thomas Keller - RBC Capital Markets Iris Long - Berenberg David Larsen - BTIG Operator Thank you for standing by and welcome t ...
Health Catalyst(HCAT) - 2021 Q3 - Quarterly Report
2021-11-09 21:34
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its cha ...
Health Catalyst(HCAT) - 2021 Q2 - Earnings Call Transcript
2021-08-08 23:44
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2021 Earnings Conference Call August 5, 2021 5:00 PM ET Company Participants Adam Brown - Senior Vice President, Investor Relations & Financial Planning & Analysis Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Sean Wieland - Piper Sandler Elizabeth Anderson - Evercore Stephanie Davis - SVB Leerink Richard Close - Canaccord Genuity John Ransom - Raymond James Dav ...
Health Catalyst(HCAT) - 2021 Q2 - Quarterly Report
2021-08-05 22:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or HEALTH CATALYST, INC. (Exact name of registrant as specified in its charter) ________________ Delaware 45-3337483 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 10897 South River Front Parkwa ...